Sequencing checkpoint inhibitor therapy in renal cell carcinoma
Lancet
.
2023 Jul 15;402(10397):160-161.
doi: 10.1016/S0140-6736(23)01058-9.
Epub 2023 Jun 5.
Authors
Kathryn E Beckermann
1
,
Brian I Rini
2
Affiliations
1
Vanderbilt Ingram Cancer Center Nashville, TN 37232, USA.
2
Vanderbilt Ingram Cancer Center Nashville, TN 37232, USA. Electronic address: brian.rini@vumc.org.
PMID:
37290460
DOI:
10.1016/S0140-6736(23)01058-9
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Agents* / therapeutic use
Carcinoma, Renal Cell* / drug therapy
Carcinoma, Renal Cell* / pathology
Humans
Kidney Neoplasms* / drug therapy
Kidney Neoplasms* / pathology
Substances
Antineoplastic Agents